TCG Opportunity III GP, LLC, 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 184,272 shares at $5.00 ($921K) on 2023-01-31, disclosed to the SEC on 2023-02-01.
Open-market purchase of $921k NGM by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 7,542 | $38K | 4.1% |
| 2 | $5.00 | 176,730 | $884K | 95.9% |
| Total | $5.00 avg | 184,272 | $921K | 100% |
| Filing → |
| NGM | BUY | 2023-01-23 | $191K | — | Filing → |
| NGM | BUY | 2023-01-17 | $27K | — | Filing → |
| NGM | BUY | 2022-12-14 | $1K | — | Filing → |